Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists

Abstract This observational study explored the association between proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) use and the risk of chronic kidney disease (CKD). Using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) and six-hospital electronic health...

Full description

Bibliographic Details
Main Authors:	Takhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-12-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-48430-9

Similar Items

Long-term use of proton-pump inhibitor on Alzheimer’s disease: a real-world distributed network analysis of six observational Korean databases using a Common Data Model
by: Yerim Kim, et al.
Published: (2022-11-01)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023-08-01)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
by: Myung Jin Song, et al.
Published: (2021-09-01)

Comparison and Analysis of Delirium Induced by Histamine H2 Receptor Antagonists and Proton Pump Inhibitors in Cancer Patients
by: Shiro Fujii, et al.
Published: (2012-07-01)

Clinically Significant Gastrointestinal Bleeding Using Proton Pump Inhibitors or Histamine Type-2 Receptor Antagonists in Patients Intubated for Over 48 Hours:
by: Waleed Khokher
Published: (2023-05-01)

Algorithm for pharmacists from community pharmacies who dispense over-the-counter proton pump inhibitors and histamine receptor antagonists for patients reporting symptoms of reflux
by: Elżbieta Jaworska, et al.
Published: (2024-01-01)

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
by: Alessandro Rizzo, et al.
Published: (2022-03-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

Prescribing Pattern of Proton Pump Inhibitors (PPI) and Histamine Blockers in a Tertiary Care Hospital
by: Anjali Manoj Goyal, et al.
Published: (2020-10-01)

Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis
by: Hiroki Matsui, et al.
Published: (2020-09-01)

Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis
by: Xin Jiang, et al.
Published: (2019-09-01)

Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
by: Seung In Seo, et al.
Published: (2022-09-01)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
by: Xiaoyang Zhou, et al.
Published: (2019-11-01)

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies
by: Chieh-Chen Wu, et al.
Published: (2023-03-01)

Proton Pump Inhibitors and Kidney Disease—GI Upset for the Nephrologist?
by: Stephanie M. Toth-Manikowski, et al.
Published: (2017-05-01)

Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database
by: Jun Suzuki, et al.
Published: (2020-07-01)

Synthesis of Gallic Acid Analogs as Histamine and Pro-Inflammatory Cytokine Inhibitors for Treatment of Mast Cell-Mediated Allergic Inflammation
by: Xiang Fei, et al.
Published: (2017-05-01)

Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)

Issues on the Stress Ulcer Prophylaxis Using Proton Pump Inhibitor in Intensive Care Unit
by: Jae Ho Cho, et al.
Published: (2019-08-01)

Is hypomagnesemia associated with using proton pump inhibitors?
by: Joo-Hark Yi, et al.
Published: (2016-06-01)

Association of Histamine-2 Blockers and Proton-Pump Inhibitors With Delirium Development in Critically Ill Adults: A Retrospective Cohort Study
by: Ami Shiddapur, BS, et al.
Published: (2021-08-01)

Histamine antagonists promote cancer immunosurveillance
by: Peng Liu, et al.
Published: (2023-12-01)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
by: Sergey A. Siletsky
Published: (2023-05-01)

Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
by: Tien Budi Febriani, et al.
Published: (2014-08-01)

Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness
by: Danziger, John, et al.
Published: (2017)

Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
by: Nobuhiko Arai, et al.
Published: (2017-01-01)

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

Pharmacogenetics of proton pump inhibitors
by: M. V. Leonova
Published: (2015-12-01)

In search of potent histamine-3 receptor antagonists
by: Sankar Chatterjee
Published: (2015-04-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
by: John Hughes, et al.
Published: (2018-01-01)

Proton Pump Inhibitor Long-term Prescription, Is It Safe?
by: Tae Ho Kim
Published: (2020-06-01)

Effect of a Proton Pump Inhibitor on the Duodenum Microbiome of Gastric Ulcer Patients
by: Jung-Hyun Lim, et al.
Published: (2022-09-01)

A Deep Recurrent Neural Network-Based Explainable Prediction Model for Progression from Atrophic Gastritis to Gastric Cancer
by: Hyon Hee Kim, et al.
Published: (2021-07-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease.
by: Min Kyoung Kang, et al.
Published: (2022-01-01)

1-Arylsulfonyl-2-(Pyridylmethylsulfinyl) Benzimidazoles as New Proton Pump Inhibitor Prodrugs
by: Young-moon Cho, et al.
Published: (2009-12-01)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017-12-01)

Pointing the finger at proton pump inhibitors
by: Emma L Walton
Published: (2014-08-01)

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)